Delivery Order SPE2DR25D3005-SPE2DR26FP7HR
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,512.27 to AmerisourceBergen Drug Corp for the supply of Ropinirole HCL ER 4 mg tablets (30-count packaging) under a firm fixed price contract type. The award, issued on September 12, 2025, with an ultimate completion date of September 15, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this...
- The Defense Logistics Agency awarded a delivery order valued at $6,172.67 to AmerisourceBergen Drug Corp for Ropinirole HCL ER 2 mg tablets (90-count supply). This competitive award, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a firm fixed-price transaction with no set-aside designation. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, which serves as AmerisourceBergen's corporate headquarters and primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Ropinirole HCl ER 6 mg tablets (30-count) with a ceiling value of $1,420.74. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The order is scheduled for completion by August 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed-price delivery order valued at $21,120 to Amerisourcebergen Drug Corporation for 100 tablets of 0.5 mg Ropinirole HCl to be delivered to its Conshohocken, Pennsylvania facility. As a prime contractor on an indefinite-delivery/indefinite-quantity contract vehicle, Amerisourcebergen will supply the pharmaceutical product to the Defense Logistics Agency to support its medical logistics programs. The delivery order has a...
- The Defense Logistics Agency awarded a $105,450 delivery order to AmerisourceBergen Drug Corporation for the supply of 4561504241 Ropinirole HCL 1 MG tablets. Under this firm fixed price contract, AmerisourceBergen will deliver 100 count bottles of the generic Parkinson's disease medication to a facility in Conshohocken, Pennsylvania by July 17, 2023 in support of the Defense Logistics Agency's medical supply needs. No subcontractors or set aside designations were identified. The delivery...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the delivery of 4 milligram Ropinirole Hydrochloride extended-release tablets, a generic medication used to treat Parkinson's disease. The ceiling value of the delivery order is $3,345.60 and the ultimate completion date is December...
- The Defense Logistics Agency Troop Support Medical awarded a $8,180 delivery order to Amerisourcebergen Drug Corporation for 4562279910 Ropinirole HCL 4 MG tablets. The firm fixed price order is for 100 count bottles of the pharmaceutical product, to be delivered to Amerisourcebergen's facility in Conshohocken, Pennsylvania by September 25, 2023. No additional details were provided regarding the original solicitation or whether this delivery order is associated with any broader indefinite...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $836.96 to Amerisourcebergen Drug Corp for the supply of 90 Ropinirole HCL ER 2 mg tablets. As the prime contractor, Amerisourcebergen Drug Corp will deliver the pharmaceutical products to a facility in Conshohocken, Pennsylvania under a one-day period of performance beginning August 2nd and concluding on August 3rd, 2023. The Defense Logistics Agency routinely utilizes indefinite delivery/indefinite quantity...
- The Defense Logistics Agency Troop Support Medical awarded a $63,750 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 units of 2 mg ropinirole hydrochloride tablets. The place of performance is Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is August 31, 2023 through September 1, 2023. This delivery order was awarded under an indefinite-delivery/indefinite-quantity contract vehicle held by Amerisourcebergen to supply...
- The Defense Logistics Agency awarded a delivery order valued at $2,676.05 to AmerisourceBergen Drug Corp for the supply of Ropinirole HCL ER 8 mg tablets (30-count package), a generic medication primarily used to treat Parkinson's disease and restless leg syndrome. The contract employs firm fixed pricing with no set-aside designation, indicating it was competitively awarded. The award date of July 29, 2025, with an ultimate completion date of July 30, 2025, reflects the expedited nature of...
- SPE2DR25D3005Indefinite Delivery Contract
- SPE2DR25D3005-SPE2DR26FP7HRDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,083.84 to AmerisourceBergen Drug Corp for the supply of Ropinirole HCL ER 12 mg tablets (30-count packaging) on November 18, 2025, with an ultimate completion date of November 19, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026, which serves as the primary vehicle for pharmaceutical and medical supply procurement to support military healthcare systems globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company maintains an extensive portfolio of federal contract awards covering a broad spectrum of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This delivery order for neurological treatment medication aligns with the company's established role as a primary pharmaceutical vendor supporting military medical supply chains across multiple therapeutic categories and geographic regions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 11/18/25 |